Emergent Product Development

Emergent BioSolutions is a global life sciences company focused on providing preparedness and response solutions for accidental, intentional, and naturally occurring public health threats. The company is best known for its portfolio of medical countermeasures, including Narcan (naloxone HCl) Nasal Spray for opioid overdose reversal and vaccines for anthrax and smallpox. Emergent also operates as a contract development and manufacturing organization (CDMO), providing services for biologics and sterile injectable products. Its business model is heavily integrated with government procurement, particularly through the U.S. Strategic National Stockpile.